<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.rcuk.ac.uk/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/5EE55E7A-9A75-4570-A04D-D9F36C3129EC"><gtr:id>5EE55E7A-9A75-4570-A04D-D9F36C3129EC</gtr:id><gtr:name>National Institutes of Health</gtr:name><gtr:address><gtr:line1>31 Center Drive</gtr:line1><gtr:line2>9000 Rockville Pike</gtr:line2><gtr:postCode>20892</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/406C62B6-F6C8-4942-8485-1176EF54B28F"><gtr:id>406C62B6-F6C8-4942-8485-1176EF54B28F</gtr:id><gtr:name>HIV i-Base</gtr:name><gtr:address><gtr:line1>HIV Clinical Care</gtr:line1><gtr:line2>1 Mountview Court</gtr:line2><gtr:postCode>N20 0LD</gtr:postCode><gtr:region>Unknown</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/2DB7ED73-8E89-457A-A395-FAC12F929C1A"><gtr:id>2DB7ED73-8E89-457A-A395-FAC12F929C1A</gtr:id><gtr:name>University of Edinburgh</gtr:name><gtr:address><gtr:line1>Old College</gtr:line1><gtr:line2>South Bridge</gtr:line2><gtr:line3>Mayfield Road</gtr:line3><gtr:line4>Edinburgh</gtr:line4><gtr:postCode>EH8 9YL</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/C938B173-5DDC-45B5-99C4-2516368FAD32"><gtr:id>C938B173-5DDC-45B5-99C4-2516368FAD32</gtr:id><gtr:name>Public Health England (formerly: Health Protection Agency)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/A6E6C042-46F9-434B-970F-5F9C8BCF6F1A"><gtr:id>A6E6C042-46F9-434B-970F-5F9C8BCF6F1A</gtr:id><gtr:name>PENTA Foundation</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/EDF9EB53-008B-4F75-A492-AC1ADCFE76F0"><gtr:id>EDF9EB53-008B-4F75-A492-AC1ADCFE76F0</gtr:id><gtr:name>Royal Free Hampstead NHS Trust</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/78308CAA-8483-45C0-A280-0AB4B6AD9D35"><gtr:id>78308CAA-8483-45C0-A280-0AB4B6AD9D35</gtr:id><gtr:name>Medical Research Council</gtr:name><gtr:address><gtr:line1>Polaris House</gtr:line1><gtr:line2>North Star Avenue</gtr:line2><gtr:postCode>SN2 1FL</gtr:postCode><gtr:region>South West</gtr:region></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.rcuk.ac.uk:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:department>Unlisted</gtr:department><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/5EE55E7A-9A75-4570-A04D-D9F36C3129EC"><gtr:id>5EE55E7A-9A75-4570-A04D-D9F36C3129EC</gtr:id><gtr:name>National Institutes of Health</gtr:name><gtr:address><gtr:line1>31 Center Drive</gtr:line1><gtr:line2>9000 Rockville Pike</gtr:line2><gtr:postCode>20892</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/406C62B6-F6C8-4942-8485-1176EF54B28F"><gtr:id>406C62B6-F6C8-4942-8485-1176EF54B28F</gtr:id><gtr:name>HIV i-Base</gtr:name><gtr:address><gtr:line1>HIV Clinical Care</gtr:line1><gtr:line2>1 Mountview Court</gtr:line2><gtr:postCode>N20 0LD</gtr:postCode><gtr:region>Unknown</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/2DB7ED73-8E89-457A-A395-FAC12F929C1A"><gtr:id>2DB7ED73-8E89-457A-A395-FAC12F929C1A</gtr:id><gtr:name>University of Edinburgh</gtr:name><gtr:address><gtr:line1>Old College</gtr:line1><gtr:line2>South Bridge</gtr:line2><gtr:line3>Mayfield Road</gtr:line3><gtr:line4>Edinburgh</gtr:line4><gtr:postCode>EH8 9YL</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/C938B173-5DDC-45B5-99C4-2516368FAD32"><gtr:id>C938B173-5DDC-45B5-99C4-2516368FAD32</gtr:id><gtr:name>Public Health England (formerly: Health Protection Agency)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/A6E6C042-46F9-434B-970F-5F9C8BCF6F1A"><gtr:id>A6E6C042-46F9-434B-970F-5F9C8BCF6F1A</gtr:id><gtr:name>PENTA Foundation</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/EDF9EB53-008B-4F75-A492-AC1ADCFE76F0"><gtr:id>EDF9EB53-008B-4F75-A492-AC1ADCFE76F0</gtr:id><gtr:name>Royal Free Hampstead NHS Trust</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/78308CAA-8483-45C0-A280-0AB4B6AD9D35"><gtr:id>78308CAA-8483-45C0-A280-0AB4B6AD9D35</gtr:id><gtr:name>Medical Research Council</gtr:name><gtr:address><gtr:line1>Polaris House</gtr:line1><gtr:line2>North Star Avenue</gtr:line2><gtr:postCode>SN2 1FL</gtr:postCode><gtr:region>South West</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/E7EC8F72-BE65-417D-BEFB-F4B23DD7A691"><gtr:id>E7EC8F72-BE65-417D-BEFB-F4B23DD7A691</gtr:id><gtr:firstName>Elizabeth</gtr:firstName><gtr:otherNames>G</gtr:otherNames><gtr:surname>Lyall</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/B5DC37E4-CF3A-4449-93B8-248F379836B7"><gtr:id>B5DC37E4-CF3A-4449-93B8-248F379836B7</gtr:id><gtr:firstName>Patricia</gtr:firstName><gtr:otherNames>Ann</gtr:otherNames><gtr:surname>Tookey</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/4E26294B-A0D9-4321-A707-04E705584A4C"><gtr:id>4E26294B-A0D9-4321-A707-04E705584A4C</gtr:id><gtr:firstName>Catherine</gtr:firstName><gtr:surname>Peckham</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.rcuk.ac.uk:80/projects?ref=G0000876"><gtr:id>53A5EF49-C36B-4D7D-BB77-AA56B638E56B</gtr:id><gtr:title>Follow up of children exposed to antiretroviral therapy in pregnancy</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0000876</gtr:grantReference><gtr:abstractText>Abstracts are not currently available in GtR for all funded research. This is normally because the abstract was not required at the time of proposal submission, but may be because it included sensitive information such as personal details.</gtr:abstractText><gtr:fund><gtr:end>2006-04-30</gtr:end><gtr:funder url="http://gtr.rcuk.ac.uk:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2001-05-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>371907</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>University College London (UCL)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>European Collaborative Study (ECS)</gtr:department><gtr:description>ECS NSHPC collaboration</gtr:description><gtr:id>144FE389-F596-44FB-821F-AA89905E752D</gtr:id><gtr:impact>Joint presentations, involvement of NSHPC in European network, joint proposals under development. Some joint publications but not directly related to uninfected follow up. Collaborating on pharmacovigilance analyses with ECS and other European colleagues through the PENTA Foundation</gtr:impact><gtr:partnerContribution>Close working relationship (ECS and NSHPC both based in the ICH MRC Centre of Epidemiology for Child Health), joint analyses, joint supervision of PhD students, on-going collaboration to develop further research proposals.</gtr:partnerContribution><gtr:piContribution>We have carried out joint analyses, for example following requests related to pharmacovigilance, and are developing joint proposals for future work on prevention of mother to child transmission, pharmacovigilance, and monitoring long term outcome in uninfected children of exposure to antiretrovirals in fetal life.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Edinburgh</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>School of Biological Sciences Edinburgh</gtr:department><gtr:description>Enhanced IT Framework</gtr:description><gtr:id>7BA87B8A-DBC7-4A9E-AA8E-ADFBDB001813</gtr:id><gtr:impact>Presentation to UK-CAB, June 2010. Multi-disciplinary: epidemiology, laboratory, patient involvement.</gtr:impact><gtr:partnerContribution>Developing on-going collaborative research potentialDeveloping IT frameworkDeveloping on-going collaborative research potentialDeveloping on-going collaborative research potentialDeveloping on-going collaborative research potentialDeveloping patient-public involvement</gtr:partnerContribution><gtr:piContribution>Co-investigator and collaborator in project to develop IT framework and public-patient involvement in national HIV databases</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Public Health England (formerly: Health Protection Agency)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Centre for Infections (CFI)</gtr:department><gtr:description>HPA Collaboration</gtr:description><gtr:id>ED14B6DC-E8E7-4AFA-AF9F-F5F9E6F25A7D</gtr:id><gtr:impact>Substantial input into HPA reports on HIV. Monitoring impact of antenatal screening policy on HIV on diagnosis in pregnancy and prevention of mother to child transmission of infection. We collaborate on publications, presentations etc, but not specifically on the CHART study.</gtr:impact><gtr:partnerContribution>Enables collection of surveillance data on HIV in pregnant women, and paediatric reporting of infected and exposed children. HPA colleagues contribute to interpretation of data, and participate in steering group.</gtr:partnerContribution><gtr:piContribution>We provide the national data on HIV in pregnant women, and paediatric HIV, which is combined at the HPA and Health Protection Scotland with other national HIV data. This collaboration was originally established in1989,funded by AVERT (charity). The DH subsequently provided funding, which came via the HPA from 2005 onwards. Further 3 year collaboration agreement between HPA and the ICH/NSHPC were made in 2008, and in 2011.</gtr:piContribution><gtr:sector>Public</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University College London (UCL)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>UCL Population Health</gtr:department><gtr:description>Enhanced IT Framework</gtr:description><gtr:id>DC50C22B-356E-4112-89ED-EA25E9F9C26D</gtr:id><gtr:impact>Presentation to UK-CAB, June 2010. Multi-disciplinary: epidemiology, laboratory, patient involvement.</gtr:impact><gtr:partnerContribution>Developing on-going collaborative research potentialDeveloping IT frameworkDeveloping on-going collaborative research potentialDeveloping on-going collaborative research potentialDeveloping on-going collaborative research potentialDeveloping patient-public involvement</gtr:partnerContribution><gtr:piContribution>Co-investigator and collaborator in project to develop IT framework and public-patient involvement in national HIV databases</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>National Institutes of Health (NIH)</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>Antiretroviral Pregnancy Registry</gtr:department><gtr:description>Antiretroviral Pregnancy Registry</gtr:description><gtr:id>F3B80765-BA46-46FA-8DAB-6D1CC5760FF8</gtr:id><gtr:impact>Updated interim reports from the APR are published bi-annually on-line at http://www.apregistry.com/ and include our aggregated table.</gtr:impact><gtr:partnerContribution>The APR is sponsored by a consortium of pharmaceutical companies, and managed by Kendle International Inc, and was established to monitor birth defects in infants exposed to antiretroviral drugs in fetal life. Most reports are from individual clinicians, mainly from the USA. Now (2012 on) managed by INC Research.</gtr:partnerContribution><gtr:piContribution>We contribute an annual aggregated UK data table to the APR. No patient identifiers are provided.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>HIV i-Base</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Enhanced IT Framework</gtr:description><gtr:id>A18E50DF-0ABF-43AD-9793-BF77213DB140</gtr:id><gtr:impact>Presentation to UK-CAB, June 2010. Multi-disciplinary: epidemiology, laboratory, patient involvement.</gtr:impact><gtr:partnerContribution>Developing on-going collaborative research potentialDeveloping IT frameworkDeveloping on-going collaborative research potentialDeveloping on-going collaborative research potentialDeveloping on-going collaborative research potentialDeveloping patient-public involvement</gtr:partnerContribution><gtr:piContribution>Co-investigator and collaborator in project to develop IT framework and public-patient involvement in national HIV databases</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Public Health England (formerly: Health Protection Agency)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Centre for Infections (CFI)</gtr:department><gtr:description>Enhanced IT Framework</gtr:description><gtr:id>5B50B3FA-5A05-4A82-BA04-23488E8FC8B6</gtr:id><gtr:impact>Presentation to UK-CAB, June 2010. Multi-disciplinary: epidemiology, laboratory, patient involvement.</gtr:impact><gtr:partnerContribution>Developing on-going collaborative research potentialDeveloping IT frameworkDeveloping on-going collaborative research potentialDeveloping on-going collaborative research potentialDeveloping on-going collaborative research potentialDeveloping patient-public involvement</gtr:partnerContribution><gtr:piContribution>Co-investigator and collaborator in project to develop IT framework and public-patient involvement in national HIV databases</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>PENTA Foundation</gtr:collaboratingOrganisation><gtr:country>France, French Republic</gtr:country><gtr:description>ECS NSHPC collaboration</gtr:description><gtr:id>DABF1C63-E9B3-4C4B-AECC-A1963506CE5B</gtr:id><gtr:impact>Joint presentations, involvement of NSHPC in European network, joint proposals under development. Some joint publications but not directly related to uninfected follow up. Collaborating on pharmacovigilance analyses with ECS and other European colleagues through the PENTA Foundation</gtr:impact><gtr:partnerContribution>Close working relationship (ECS and NSHPC both based in the ICH MRC Centre of Epidemiology for Child Health), joint analyses, joint supervision of PhD students, on-going collaboration to develop further research proposals.</gtr:partnerContribution><gtr:piContribution>We have carried out joint analyses, for example following requests related to pharmacovigilance, and are developing joint proposals for future work on prevention of mother to child transmission, pharmacovigilance, and monitoring long term outcome in uninfected children of exposure to antiretrovirals in fetal life.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Medical Research Council (MRC)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>MRC Clinical Trials Unit</gtr:department><gtr:description>Enhanced IT Framework</gtr:description><gtr:id>468CB9F3-07C4-4394-9BB0-63D0321E86F6</gtr:id><gtr:impact>Presentation to UK-CAB, June 2010. Multi-disciplinary: epidemiology, laboratory, patient involvement.</gtr:impact><gtr:partnerContribution>Developing on-going collaborative research potentialDeveloping IT frameworkDeveloping on-going collaborative research potentialDeveloping on-going collaborative research potentialDeveloping on-going collaborative research potentialDeveloping patient-public involvement</gtr:partnerContribution><gtr:piContribution>Co-investigator and collaborator in project to develop IT framework and public-patient involvement in national HIV databases</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Royal Free Hampstead NHS Trust</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Royal Free Hospital</gtr:department><gtr:description>Enhanced IT Framework</gtr:description><gtr:id>BD41ECD9-3F2D-4AB0-A59F-5C73D04D00D4</gtr:id><gtr:impact>Presentation to UK-CAB, June 2010. Multi-disciplinary: epidemiology, laboratory, patient involvement.</gtr:impact><gtr:partnerContribution>Developing on-going collaborative research potentialDeveloping IT frameworkDeveloping on-going collaborative research potentialDeveloping on-going collaborative research potentialDeveloping on-going collaborative research potentialDeveloping patient-public involvement</gtr:partnerContribution><gtr:piContribution>Co-investigator and collaborator in project to develop IT framework and public-patient involvement in national HIV databases</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>NSHPC website</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>B30C74F9-74D7-4C0F-BDF6-784C54C8C09A</gtr:id><gtr:impact>NSHPC website: www.ucl.ac.uk/nshpc Includes details of papers, presentations and summary report on CHART study.

Publicly available information about national HIV surveillance in pregnant women and children, and follow up of children</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2008,2009,2010,2011,2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Poster International AIDS Conference Toronto</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>1A3C26C7-8E18-4162-A8BD-A98BB80C1604</gtr:id><gtr:impact>Poster presentation at 16th International AIDS Conference, Toronto 2006. Title: Feasibility of clinic-based follow-up of uninfected children born to HIV-infected women in the UK: the Children exposed to ART study (CHART). Hankin CD, Lyall EGH, Masters JI, Peckham CS, Tookey PA. Abstract TUPE0328. Mixed audience of clinicians, scientists, people living with HIV/AIDS

Dissemination of information about the study</gtr:impact><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2006</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Clinic report for parents</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>7DFE880D-29EA-47FD-9E65-ED3221A314BE</gtr:id><gtr:impact>Written report for clinic staff to display in clinics where the parent survey was carried out, and to distribute to parents who participated. Used to inform parents (both participants and non-participants) of the findings.

Contributed to awareness of parents attending HIV clinics, and also to general awareness of staff about the study and findings.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:year>2007</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>HIV support and patient groups</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>7AB78343-0451-43E9-BF58-F5BCABA08691</gtr:id><gtr:impact>We have presented our findings on management of pregnancy in HIV infected women, and the implications of fetal exposure to ART, at informal and formal meetings organised by or for people living with HIV, for example Positively Women, Body and Soul, National Children's Bureau, UK-CAB.

Dissemination of information about the management of HIV in pregnancy, and implications for families, to people affected by HIV. These activities also feed back into how we manage our research and publicise our findings. The NSHPC steering group includes patient representatives, as did the CHART steering group.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:year>2006,2007,2008,2009,2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>UK-CAB presentation</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>35F438C0-359D-4A48-B2DF-209F696F1FDD</gtr:id><gtr:impact>20 attendees at CAB Community Training Day for HIV treatment advocates. Collaborators from the IT study group outlined their research work and objectives, with discussion particularly on ethics, governance, confidentiality and potential for community involvement in research.

Improved awareness of HIV research and surveillance among HIV-affected community, and enhanced interaction between public and researchers.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>NSHPC Newsletter</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>5CA79FFE-34FD-474E-B8F8-35D75A9F5E37</gtr:id><gtr:impact>Quarterly NSHPC Newsletter - at least once a year included information about publications and presentations in which CHART data were included.

Dissemination of findings to health professionals and others who receive the newsletter; this is available on-line at www.ucl.ac.uk/nshpc and is distributed in hard copy to respondents to the NSHPC (&amp;gt;250) and relevant patient groups and organisations.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:url>http://www.ucl.ac.uk/nshpc</gtr:url><gtr:year>2006,2007,2008,2009,2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>RCPCH Presentation 2009</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>CFF97AAB-5090-4372-9C39-AE63BFD40443</gtr:id><gtr:impact>Oral presentation giving update on progress with flagging uninfected children with ONS, for monitoring death and cancer, and preliminary findings

Dissemination of information to paediatricians about long-term monitoring of children exposed to antiretrovirals in fetal life</gtr:impact><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>CHIVA Evening Meetings</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>A2F5291A-4D9B-4B79-9AC7-B345514D1D5D</gtr:id><gtr:impact>Gave annual updates on progress of and findings from follow up of uninfected exposed children. Education and clinical discussion meetings for health professionals (mainly London-based) - paediatricians, clinical nurse specialists, pharmacists, and other paediatric HIV team members. Average attendance 30-50 people.

Dissemination of current research findings to health professionals specifically working with HIV-infected pregnant women, and their infected and uninfected children.</gtr:impact><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2006,2007,2008,2009,2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Presentations at Study Days for Health Professionals</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>9461E32C-977C-4B85-947F-17E8CF10B770</gtr:id><gtr:impact>Incorporated findings from CHART study into various workshops and study days, mostly aimed at midwives, paediatricians, clinical nurse specialists, other health professionals working in HIV field.

Enhanced knowledge and awareness of health professionals working with HIV-infected people.</gtr:impact><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2006,2007,2008,2009,2010</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>140295</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Training Fellowship</gtr:description><gtr:end>2009-08-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>B2A175F8-FC72-4EBE-848C-28031A8867D1</gtr:id><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-09-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Evidence base for HIV health professionals</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>641D20CE-B14D-464F-9D51-841E59E51764</gtr:id><gtr:impact>There are limited data on the safety of fetal exposure to antiretroviral drugs. The CHART study provided some preliminary information for professionals to use in their discussions with and advice for pregnant women and families.</gtr:impact><gtr:type>Influenced training of practitioners or researchers</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Citation in British HIV Association Pregnancy Management Guidelines</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>EAB88186-8922-4A3D-984F-CF474340597D</gtr:id><gtr:impact>Quantitative information about the impact of exposure to ARVs in fetal life, especially on HIV-exposed but uninfected children.</gtr:impact><gtr:type>Membership of a guidance committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Intercollegiate Working Party Report</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>BAEBDA42-0F6A-4F94-BF0E-2F85EA4EEDCE</gtr:id><gtr:impact>Findings from the CHART study were reported in the Update Report of an Intercollegiate Working Party: Reducing Mother to Child Transmission of HIV Infection in the UK. July 2006. RCPCH. Dissemination of findings to health professionals, commissioners and policy makers</gtr:impact><gtr:type>Citation in other policy documents</gtr:type></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>Algorithm developed, refined and established for linking data on children (names not available) exposed to antiretroviral therapy (and HIV) in fetal life with national (ONS) data on cancer registration and death. MRC funding (1999) was also originally provided for a pilot study.</gtr:description><gtr:id>CA15211F-3326-4FBB-9AAE-B2CBFEAA40F4</gtr:id><gtr:impact>Long-term anonymised follow up of ART exposed children is established, for death and cancer. Pharmacovigilance potential since individual antiretroviral drugs, and timing of exposure, are prospectively collected. Unique system internationally as comprehensive reporting of exposed children and link to national cancer data not available elsewhere.</gtr:impact><gtr:providedToOthers>false</gtr:providedToOthers><gtr:softwareDeveloped>true</gtr:softwareDeveloped><gtr:title>ONS flagging</gtr:title><gtr:type>Improvements to research infrastructure</gtr:type></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/2B5CAF22-498F-442A-95DF-010512A748EF"><gtr:id>2B5CAF22-498F-442A-95DF-010512A748EF</gtr:id><gtr:title>Monitoring death and cancer in children born to HIV-infected women in England and Wales: use of HIV surveillance and national routine data.</gtr:title><gtr:parentPublicationTitle>AIDS (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/c3ad80093aba13a2baa638ebf32343d4"><gtr:id>c3ad80093aba13a2baa638ebf32343d4</gtr:id><gtr:otherNames>Hankin C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0269-9370</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/1EEF169C-8EB9-48F0-86FC-E2CF39DE9562"><gtr:id>1EEF169C-8EB9-48F0-86FC-E2CF39DE9562</gtr:id><gtr:title>In utero exposure to antiretroviral therapy: feasibility of long-term follow-up.</gtr:title><gtr:parentPublicationTitle>AIDS care</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/c3ad80093aba13a2baa638ebf32343d4"><gtr:id>c3ad80093aba13a2baa638ebf32343d4</gtr:id><gtr:otherNames>Hankin C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0954-0121</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/388BAE4F-08DF-4CC4-94CF-C0CBFA1F2EE8"><gtr:id>388BAE4F-08DF-4CC4-94CF-C0CBFA1F2EE8</gtr:id><gtr:title>Long-term follow-up of uninfected children born to HIV-infected women and exposed to antiretroviral therapy: survey of parents' and health professionals' views.</gtr:title><gtr:parentPublicationTitle>AIDS care</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/8d455f67a53cb64c7661ffa7436b3b71"><gtr:id>8d455f67a53cb64c7661ffa7436b3b71</gtr:id><gtr:otherNames>Hankin CD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0954-0121</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/3E99E76D-C1D5-4B37-9878-8555502C0002"><gtr:id>3E99E76D-C1D5-4B37-9878-8555502C0002</gtr:id><gtr:title>Strategies for Monitoring Outcomes in HIV-Exposed Uninfected Children in the United Kingdom.</gtr:title><gtr:parentPublicationTitle>Frontiers in immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/3642291d4f808eb3d4339525a1dfe49f"><gtr:id>3642291d4f808eb3d4339525a1dfe49f</gtr:id><gtr:otherNames>Thorne C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1664-3224</gtr:issn></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0000876</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>03BA7BC9-C251-48FC-8EA9-5F7414A63FEE</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>Infection</gtr:text></gtr:healthCategory><gtr:healthCategory><gtr:id>FA7AA693-7EDD-4A7E-8CA3-6B5658FBF717</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>Reproductive Health and Childbirth</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>9A8BEDCC-D902-4C9A-8CCF-C974265EA3FB</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>2.4  Surveillance and distribution</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>7135039D-2DB0-4D41-87B3-FA1C8D38E133</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>6.1  Pharmaceuticals</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>